Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

13 Jan 2017 Evaluate

Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on January 24, 2017, to consider, approving and taking on record Unaudited (Consolidated & Standalone) Financial Results of the Company for the third quarter ended December 31, 2016 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..